Catalyst Wire Dossier Catalyst Wire Dossier

64Cu-Plerixafor

plerixafor (radiolabeled copper-64 imaging agent)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-Plerixafor, covering 2018-07-12 to 2018-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor [EARLY_Phase 1]

See pricing